Telix Pharmaceuticals
Telix Pharmaceuticals Logo
About Telix Pharmaceuticals
Telix Pharmaceuticals Ltd is a commercial-stage biopharmaceutical company specializing in the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases. The company delivers targeted radiation to cancer cells through systemic radioactive infusions, enabling precision treatment of tumors throughout the body. Telix's product portfolio includes Illuccix for prostate cancer imaging, as well as a pipeline of candidates for prostate, kidney, brain, and soft tissue cancers, and bone marrow conditioning. Operating globally, Telix serves patients in Australia, the United States, Europe, and Asia.
Address
55 Flemington Road, Suite 401
North Melbourne, 3051
Australia
Year founded
2017
Number of employees
1,000-2,000
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
